-The Times of India MUMBAI: There is some good news for homemakers. Oil marketing companies have introduced a new 'star rating' system for cooking gas dealers, which will ensure that LPG cylinders are refilled within a stipulated period of time. A dealer failing to provide refills on time risks losing his rating and even his licence if the delivery is not made in eight days. In the most-privileged category are the dealers...

-The Economic Times NEW DELHI: With paddy arrivals yet to pick up across Punjab, the state government now plans to make direct payments to farmers. The move is aimed to protect farmer's interest particularly the small and marginal from being exploited by the commission agents/arthiyas. The issue of direct procurement and payment to farmers had been delayed for several years with both the Congress ruled and Akali-BJP government not keen to upset...

-The Hindu The Supreme Court's latest order on Aadhaar card seems to have little bearing on the ongoing enrolment in the National Population Register (NPR). The reason is simple: it has no link with entitlements. The Supreme Court's latest order on Aadhaar card seems to have little bearing on the ongoing enrolment in the National Population Register (NPR). The reason is simple: it has no link with entitlements. Also, it is business as-usual...

-The Hindu JENVAC is the first vaccine to be manufactured in the public-private partnership mode India on Friday launched its first indigenous vaccine to protect children from Japanese encephalitis. Until now, the country has been importing the vaccine from China. The Vero cell-derived purified inactivated JE vaccine-JENVAC, which received manufacturing and marketing approvals from the Drug Controller General of India, is the first vaccine to be manufactured in the public-private partnership mode between...

-Live Mint Apex court expresses concerns about drug trials being permitted on humans without comprehensive rules to regulate the approval process New Delhi: The apex court on Monday directed the health ministry to justify its approval for 162 global clinical trials in India, increasing the uncertainty faced by the nation's $500 million clinical research industry. The Supreme Court expressed its concerns about drug trials being permitted on humans without comprehensive rules to...